Source: StreetInsider

Press Release: JDRF : New Findings from Groundbreaking Study Shows Extended Delay in Onset of Type 1 Diabetes

NEW YORK, June 15, 2020 /PRNewswire/ -- Emily Sims, M.D. today shared new findings that a breakthrough drug significantly delays the onset of type 1 diabetes (T1D). ...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Aaron J. Kowalski's photo - President & CEO of JDRF

President & CEO

Aaron J. Kowalski

CEO Approval Rating


JDRF is a non-profit organization that researches and develops novel therapeutics for the treatment of diabetic diseases. Read more